eli lilly zepbound news - Search News

Eli Lilly Will Sell Zepbound Through Telehealth Company Ro

Hosted on MSN · 11h

Eli Lilly Will Sell Zepbound Through Telehealth Company Ro in a Swipe at Legal Copycats

Amid new worries that legal copycats of the weight-loss drugs from Eli Lilly and Novo Nordisk could erode the market for the branded drugs, Lilly on Wednesday said it would sell a version of Zepbound through the telemedicine company Ro.

Business Insider · 13h

Ro, Eli Lilly to streamline patient access to Zepbound single-dose vials

Ro announced earlier that it is working with Eli Lilly (LLY) and Company to streamline access to Zepbound single-dose vials for Ro patients

Telehealth firm Ro to provide single-dose vials of Lilly's Zepbound to obesity patients

Telehealth company Ro said on Wednesday it will provide access to single-dose vials of Eli Lilly's weight-loss drug Zepbound to patients with obesity.

Eli Lilly to test weight loss drugs

What can't weight-loss meds do? Eli Lilly is going to test Zepbound as a treatment for addiction

Eli Lilly (LLY), the pharma giant that produces the popular weight-loss drug Zepbound, said it plans to test the blockbuster drug as a treatment for alcohol and drug addiction starting next year.

NBC Los Angeles · 14h

Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly

It is made possible through a first-of-a-kind integration with Eli Lilly’s direct-to-consumer website, and aims to streamline access to the popular treatment.

USA Today · 7d

Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial

Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.

Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s

Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.

13hon MSN

Eli Lilly is partnering with Ro to make it easier than ever to get Zepbound

Eli Lilly (LLY) has announced it will make lower-priced, single-dose vials of its popular weight-loss treatment Zepound ...

6don MSN

Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...

High-flying Eli Lilly plots $15B share buyback campaign

With Eli Lilly's diabetes and obesity products Mounjaro and Zepbound booming in popularity, the drugmaker finds itself in a ...

Hosted on MSN7h

Wall Street Sounds Alarm On Hims & Hers Amid Ro-Eli Lilly Zepbound Tie-Up: Retail Shrugs It Off

Shares of Hims & Hers Health Inc. slid to a three-week low on Wednesday before recovering some losses, even as retail ...

1d

Lilly approves $15 billion in share buybacks, raises dividend

Eli Lilly and Co. approved a program to buy back as much as $15 billion of its own shares amid rapid growth fueled in part by ...

2d

Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now

Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.

Outsourcing-pharma1d

Eli Lilly invests $3bn in injectable drug manufacturing facility

Including the acquisition and expansion of the manufacturing facility, Eli Lilly will be investing $4bn in the site. After ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results